PC

Punjab Chemicals

Q3 FY25Fertilizers & Agrochemicals

Punjab Chemicals Q3 FY25 earnings call: Revenue & Margins

Q3 FY25 earnings call: what management guided on revenue, margins and order book.

Price₹1,148
Market cap₹1.4K Cr
P/E21.0
Updated23 Aug 2026
Read4 min read

The short version

The Industrial Chemicals business aims to more than double revenue from around INR130 crore to approximately INR300 crore in the next 2 years. The company expects a revenue jump of 12%-14% in the next financial year (Page 8).

From Punjab Chemicals's Q3 FY25 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • The Industrial Chemicals business aims to more than double revenue from around INR130 crore to approximately INR300 crore in the next 2 years.
  • A new greenfield facility is planned between Maharashtra and Gujarat to expand phosphorus chemistry capacity, with commercialization targeted by late FY '26 or early FY '27.
  • Discussions with customers signal addition of new specialty and intermediates products, expected to contribute to sales growth starting FY '26.
  • Export demand, currently subdued, is expected to recover gradually by Q2-Q3 FY '26, improving volumes and margins.
  • Domestic market focus is increasing with new molecules contributing about 15% of revenues and expected to grow as market shares mature.

2 more points from Punjab Chemicals's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Punjab Chemicals said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • A new phosphoric acid facility is planned between Maharashtra and Gujarat, fast-tracked after a prior site was dropped for legal reasons. Exact capex details expected by Q2 FY '26. (Page 8)
  • INR 15-18 crores spent recently on onetime expenses for asset renewal, new reactors, columns, and HSE improvements. (Page 8)
  • Existing plants are undergoing process improvements and debottlenecking to cater to increasing demand without immediate large capex. (Page 7)
  • Considering outsourcing some operations to nearby facilities to capture demand upside while new greenfield projects take shape. (Page 7)

2 more points from Punjab Chemicals's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

Guidance-ranked
Rev 3Mar 3
3
Rev 3Mar 3
4
Rev 3Mar 3
5
Rev 3Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Punjab Chemicals said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • There is no specific quantitative disclosure of the current or expected order book in the transcript.
  • Discussions indicate robust ongoing order flow, especially in new product launches and domestic market expansion.
  • New orders in Industrial Chemicals involve partnerships with customers including a beverage company, with execution expected in FY '26.
  • Capacity constraints at Pune plant are addressed by exploring outsourcing and process improvements; a greenfield facility is planned for commercialization by late FY '26 or early FY '27.
  • The product pipeline is strong with multiple new molecules under development and expected launches in the near term.

2 more points from Punjab Chemicals's call on order book

Pro opens every point from 15K+ earnings calls

Punjab Chemicals — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹209 Cr, net profit ₹11 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Fertilizers & Agrochemicals this season

  • Sumitomo Chemical India Ltd (Q3 FY25)

    641.9 crore, up 18% YoY from Rs. Key concall takeaways from Sumitomo Chemical India Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.

  • Paradeep Phosphates Ltd (Q3 FY25)

    Q3 FY25 sales surged 47% YoY to 870,586 metric tons; 9 months sales up 13% YoY to 2.29 million tons. Key concall takeaways from Paradeep Phosphates Ltd's Q3…

  • Dhanuka Agritech Ltd (Q3 FY25)

    New registrations and marketing efforts are planned to revive and grow acquired Bayer products by 10-15% CAGR in subsequent years (Page 14). Key concall…

  • Coromandel International Ltd (Q3 FY25)

    550-600 crores to about Rs. Key concall takeaways from Coromandel International Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Punjab Chemicals and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Punjab Chemicals Q3 FY25 results?

The Industrial Chemicals business aims to more than double revenue from around INR130 crore to approximately INR300 crore in the next 2 years. The company expects a revenue jump of 12%-14% in the next financial year (Page 8).

What is Punjab Chemicals share price analysis?

Punjab Chemicals currently shows a neutral. The stock trades at a P/E of 21.0 with a market cap of ₹1,407 Cr. Investors should review the full earnings analysis for detailed insights.

Is Punjab Chemicals planning capital expenditure?

A new phosphoric acid facility is planned between Maharashtra and Gujarat, fast-tracked after a prior site was dropped for legal reasons.

Keep Punjab Chemicals on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.